MYRIAD GENETICS, INC. Interest Expense Nonoperating
MYRIAD GENETICS, INC. (MYGN) reported Interest Expense Nonoperating of $4.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-07-31
- MYRIAD GENETICS, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $4.10M, a 173.33% increase year-over-year.
- MYRIAD GENETICS, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $4.10M, a 412.50% increase year-over-year.
- MYRIAD GENETICS, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $4.40M, a 528.57% increase year-over-year.
- MYRIAD GENETICS, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $3.80M, a 375.00% increase year-over-year.
- MYRIAD GENETICS, INC. interest expense nonoperating for fiscal 2025 was $10.50M, a 275.00% increase from fiscal 2024.
- MYRIAD GENETICS, INC. interest expense nonoperating for fiscal 2024 was $2.80M, a 3.45% decline from fiscal 2023.
- MYRIAD GENETICS, INC. interest expense nonoperating for fiscal 2023 was $2.90M, a 9.38% decline from fiscal 2022.
- MYRIAD GENETICS, INC. interest expense nonoperating for fiscal 2022 was $3.20M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.10M 10-Q · filed 2026-07-31 | $8.20M 10-Q · filed 2026-07-31 | $12.60M derived: sum of 3 quarters · filed 2026-07-31 | $16.40M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $4.10M 10-Q · filed 2026-05-06 | $8.50M derived: sum of 2 quarters · filed 2026-05-06 | $12.30M derived: sum of 3 quarters · filed 2026-05-06 | $13.80M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.20M derived: sum of 2 quarters · filed 2026-02-24 | $9.70M derived: sum of 3 quarters · filed 2026-07-31 | $10.50M 10-K · filed 2026-02-24 |
| 2025-09-30 | $3.80M 10-Q · filed 2025-11-04 | $5.30M derived: sum of 2 quarters · filed 2026-07-31 | $6.10M 10-Q · filed 2025-11-04 | $6.80M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $1.50M 10-Q · filed 2026-07-31 | $2.30M 10-Q · filed 2026-07-31 | $3.00M derived: sum of 3 quarters · filed 2026-07-31 | $3.80M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $800.00K 10-Q · filed 2026-05-06 | $1.50M derived: sum of 2 quarters · filed 2026-05-06 | $2.30M derived: sum of 3 quarters · filed 2026-05-06 | $3.10M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.50M derived: sum of 2 quarters · filed 2026-02-24 | $2.30M derived: sum of 3 quarters · filed 2026-02-24 | $2.80M 10-K · filed 2026-02-24 |
| 2024-09-30 | $800.00K 10-Q · filed 2025-11-04 | $1.60M derived: sum of 2 quarters · filed 2025-11-04 | $2.10M 10-Q · filed 2025-11-04 | $3.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $800.00K 10-Q · filed 2025-08-06 | $1.30M 10-Q · filed 2025-08-06 | $2.20M derived: sum of 3 quarters · filed 2026-02-24 | $3.20M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $500.00K 10-Q · filed 2025-05-07 | $1.40M derived: sum of 2 quarters · filed 2026-02-24 | $2.40M derived: sum of 3 quarters · filed 2026-02-24 | $2.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.90M derived: sum of 2 quarters · filed 2026-02-24 | $2.40M derived: sum of 3 quarters · filed 2026-02-24 | $2.90M 10-K · filed 2026-02-24 |
| 2023-09-30 | $1.00M 10-Q · filed 2024-11-08 | $1.50M derived: sum of 2 quarters · filed 2024-11-08 | $2.00M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $500.00K 10-Q · filed 2024-08-07 | $1.00M 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | $3.20M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |